Mickey Iotov

Mickey Iotov is a skilled Software Quality Assurance Engineer III at Natera, leveraging over 10 years of experience in medical diagnostics and systems engineering. Previously, they held multiple positions at Roche, where they specialized in the development and validation of PCR diagnostic assays and contributed to the approval of various critical tests, including the first FDA Emergency Use Authorized Sars-Cov-2 PCR test in the US. Mickey obtained a Bachelor of Science in Molecular Cell Developmental Biology with a minor in Bioinformatics from the University of California, Santa Cruz.